House green­lights psy­che­del­ic re­search in NDAA, drug short­age and PBM re­forms to come

The House of Rep­re­sen­ta­tives passed its wide-reach­ing de­fense spend­ing bill Fri­day on a large­ly par­ty-line vote, green­light­ing a bi­par­ti­san pro­vi­sion that would di­rect the De­part­ment of De­fense to car­ry out stud­ies on the use of psy­che­delics to treat ser­vice mem­bers with con­di­tions like post-trau­mat­ic stress dis­or­der.

With about two weeks un­til Au­gust re­cess, Con­gress’ phar­ma-re­lat­ed to-do list of PBM and drug short­age re­forms, as well as pan­dem­ic pre­pared­ness, will like­ly wait for the fall.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER